FDA approves combination Therapy for pain due to Endometriosis Dr. Kamal Kant Kohli9 Aug 2022 7:30 PM ISTThe US Food and Drug Administration (FDA) has approved combination therapy containing relugolix, estradiol, and norethindrone acetate (Myfembree) for...
NRT, varenicline or cytisine reduce alcohol consumption also in addition to smoking cessation: JAMA Dr. Kamal Kant Kohli8 Aug 2022 9:30 AM ISTA clinical trial to test whether three proven smoking cessation treatments could also reduce alcohol intake found no differences between the...
FDA Approves First Targeted Therapy for HER2-Low Breast Cancer Dr. Kamal Kant Kohli6 Aug 2022 8:00 AM ISTThe U.S. Food and Drug Administration has approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV infusion for the treatment of patients with...
FDA approves new oral testosterone for hypogonadism Dr. Kamal Kant Kohli4 Aug 2022 11:00 AM ISTThe Food and drug administration has approved a new oral testosterone undecanoate (Kyzatrex) for men with hypogonadism. The new drug being...
FDA approves belimumab for lupus nephritis for pediatric patients Dr. Kamal Kant Kohli28 July 2022 10:15 AM ISTThe FDA has approved belimumab for the treatment of active lupus nephritis for children who are also receiving standard therapy. The drug is being...
Rosuvastatin linked with signs of kidney damage in real world data Dr. Kamal Kant Kohli21 July 2022 1:30 PM ISTStatins can effectively lower high cholesterol, and many individuals take rosuvastatin, one member of this drug class. New research based on patient...
FDA approves Opzelura for repigmentation in nonsegmental vitiligo Dr. Kamal Kant Kohli21 July 2022 9:00 AM ISTThe U.S. Food and Drug Administration (FDA) has approved Opzelura (ruxolitinib) cream 1.5% for the topical treatment of nonsegmental vitiligo in adult...
FDA Clears novel Neurostimulation Device to treat Diabetic Neuropathic Pain Dr. Kamal Kant Kohli19 July 2022 9:45 AM ISTThe US Food and Drug Administration has cleared a percutaneous electrical neurostimulation (PENS) device for symptomatic relief of chronic,...
No Benefit of taking Fluticasone Furoate inhaler for COVID-19 Symptoms, finds study Dr. Kamal Kant Kohli15 July 2022 1:00 AM IST A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no symptomatic or clinical benefit to...
Adults with blood cancers respond to booster, not initial dose of COVID-19 vaccine Dr. Kamal Kant Kohli13 July 2022 8:30 PM ISTPeople with hematologic malignancies-or blood cancers including leukemia, lymphoma, and multiple myeloma-have an impaired immune system due to their...
Inhaled nitric oxide improves oxygenation and reduces hospital stay in pregnant COVID-19 patients Dr. Kamal Kant Kohli10 July 2022 8:00 PM ISTHigh dose inhaled nitric oxide gas (iNO) is a safe and effective respiratory therapy for pregnant women hospitalized with severe COVID-19 pneumonia,...
FDA Fast Tracks new drug combo for treating Obstructive Sleep Apnea Dr. Kamal Kant Kohli2 July 2022 9:45 AM ISTThe Food and Drug Administration (FDA) has granted Fast Track designation to an investigational drug AD109 for the treatment of obstructive sleep...
